FOLD stock forecast
Our latest prediction for Amicus Therapeutics Inc's stock price was made on the Feb. 6, 2024 when the stock price was at 12.98$.
In the short term (2weeks), FOLD's stock price should underperform the market by -1.41%. During that period the price should oscillate between -7.39% and +0.96%.
In the medium term (3months), FOLD's stock price should underperform the market by -16.05%. During that period the price should oscillate between -30.48% and +7.48%.
Get email alertsCreate a solid portfolio with FOLD
About Amicus Therapeutics Inc
amicus therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. we have a unique set of platform technologies and medicines in development for patients living with the lysosomal storage disorders fabry disease and pompe disease and we are committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for these and other rare diseases. the needs of patients in the rare disease community are at the center of our inventive science, our commercial organization, and our clinical programs. our goal throughout all levels of the organization is to make a meaningful difference in the lives of these patients and their caregivers. several opportunities are available to join our team as we build a leading global biotechnology company focused on rare metabolic diseases. our amicus footprint spans 27 countries including our g
At the moment the company generates 16M USD in revenues.
On its last earning announcement, the company reported a loss of -0.30$ per share.
The book value per share is 2.97$
Three months stock forecastFeb. 6, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
16M | - | -115M | - | -173M | -0.30 | - | - | 290M | 2.97 | - | - | - |